The role of hydroxyurea in sickle cell disease
Open Access
- 24 January 2003
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (2) , 177-186
- https://doi.org/10.1046/j.1365-2141.2003.03849.x
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemiaThe Journal of Pediatrics, 2001
- HODGKIN'S DISEASE IN A CHILD WITH SICKLE CELL DISEASE TREATED WITH HYDROXYUREAPediatric Hematology and Oncology, 2001
- Successful hydroxyurea treatment of a patient with SD hemoglobinopathyAmerican Journal of Hematology, 1999
- Anémie falciforme chez l'enfant : intérêt de l'hydroxyurée dans les formes gravesArchives de Pédiatrie, 1997
- Clinical and hematologic effects of hydroxyurea in children with sickle cell anemiaThe Journal of Pediatrics, 1996
- Sickle Cell Anemia — Basic Research Reaches the ClinicNew England Journal of Medicine, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or HydroxyureaNew England Journal of Medicine, 1985
- Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by HydroxyureaNew England Journal of Medicine, 1984
- Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhoodThe Journal of Pediatrics, 1981